Elsevier

The Lancet Haematology

Volume 8, Issue 10, October 2021, Pages e732-e743
The Lancet Haematology

Series
Iron deficiency anaemia in sub-Saharan Africa: a review of current evidence and primary care recommendations for high-risk groups

https://doi.org/10.1016/S2352-3026(21)00193-9Get rights and content

Summary

The epidemiology of iron deficiency anaemia in sub-Saharan Africa differs from that in other parts of the world. The low-quality diets prevalent in this region are a poor source of iron, the population is frequently exposed to infection, and demographic characteristics result in a greater prevalence of people at high risk of iron deficiency anaemia than in other parts of the world. We herein review the causes, disease burden, and consequences of iron deficiency anaemia in the general population in this region, and current policies and interventions for its control. The current debate is dominated by concerns about the safety of iron interventions, namely regarding its effects on malaria and other infectious diseases. However, universal antenatal iron supplementation and delayed cord clamping are safe interventions and stand out for their potential to improve maternal and infant health. Effective infection control is a precondition to safe and efficacious iron interventions in children. Greater emphasis should be given to approaches aiming to reduce iron loss due to helminth infections and menstruation, alongside interventions to increase iron intake.

Translation

For the French translation of the abstract see Supplementary Materials section.

Introduction

The epidemiology of iron deficiency anaemia in sub-Saharan Africa differs from that in other parts of the world in three key aspects. First, despite rapid urbanisation, sub-Saharan Africa continues to have the largest share of rural population of all the world regions that are reliant on monotonous, plant-based diets.1 The staple foods of these populations are usually comprised of unrefined grains and derived products (eg, flour), which are naturally rich in substances that inhibit the intestinal absorption of non-haem iron. The low bioavailability of dietary iron partly explains why the prevalence of anaemia in sub-Saharan Africa is higher than in any other region worldwide.2 Second, people in sub-Saharan Africa are disproportionally exposed to infections. Concerns that iron interventions can increase the burden of infectious diseases, notably malaria, have been a barrier to scaling up iron interventions. Conversely, infections cause iron deficiency through blood loss and inflammation, and complicate the diagnosis of iron deficiency. Evidence is growing that infection-induced inflammation, even at low-grade levels, impairs the efficacy of iron interventions in Africa. Finally, because of demographic factors, groups at risk of iron deficiency anaemia remain disproportionally represented in Sub-Saharan Africa. The region also has the highest proportion of children younger than 5 years (15·4% of the total population, in 2019) of any world region.3 It is also the only region in the world where the population is forecasted to continuously grow over the next 80 years, from 13% (1·2 billion people, in 2017) to 35% (3·1 billion people, in 2100) of the global population.4 These forecasts are mostly driven by high fertility, so a large proportion of the sub-Saharan African population will, in the coming decades, be constituted of pregnant women and young children—two groups that are at high risk of iron deficiency anaemia. In sub-Saharan Africa, early childbearing is also generally more frequent than elsewhere in the world. In west and central Africa, 28% of women aged 20–24 years surveyed reported to have had a livebirth by their 18th birthday (with 6% of these women reporting to have had a livebirth by their 15th birthday); in eastern and southern Africa, this percentage was 25% for women of the same age (with 4% of these women reporting to have had a livebirth by their 15th birthday).5 In these adolescents, high iron requirements due to pregnancy are superimposed on those for growth, which is likely to put them at high risk of severe, life-threatening anaemia during pregnancy or after childbirth.

Key messages

Pregnant women

  • Adherence to iron supplementation during pregnancy is likely to lead to substantial reduction in post-partum, haemorrhage-induced maternal mortality and to increased birthweight

  • National programmes for antenatal iron supplementation urgently need strengthening or overhauling and international financial and technical support to improve delivery and create demand

Adolescent girls and non-pregnant women

  • Sufficient iron stores should be attained before pregnancy or between pregnancies to prevent iron deficiency and anaemia during pregnancy; insufficient attention is given in research and policies to adolescent girls, perhaps on the grounds that iron deficiency anaemia is relatively uncommon in this group

  • Policies should be reviewed to give women of reproductive age, including adolescent girls, access to contraceptives with the specific aim of controlling menstrual bleeding and its associated anaemia, and to build iron stores

Children

  • Delayed cord clamping can prevent or delay the onset of iron deficiency anaemia in late infancy, when children are most susceptible

  • As per WHO recommendations, iron interventions should not be given to children in malaria-endemic areas unless given in conjunction with measures to prevent malaria, which should be administered to individual recipients of iron interventions, rather than to a general public receiving iron interventions

General

  • Effective control of infections, especially in sub-Saharan Africa, is required to improve iron absorption and utilisation, and to make iron interventions safe and more efficacious

In this Series paper, we review the causes, burden, and consequences of iron deficiency anaemia in the general population of sub-Saharan Africa, as well as current policies and interventions for its control.

Section snippets

Normal iron nutrition across the life course

Women in sub-Saharan Africa usually start their pregnancies with absent or marginal physiological iron stores6 and are therefore likely to be anaemic in early pregnancy, or to develop iron deficiency anaemia in the course of their pregnancies. Because menstruation stops during pregnancy, iron requirements initially decrease compared with the pre-pregnancy state, and then greatly increase to meet the additional demands of iron deposition in the fetus, placenta, and umbilical cord, as well as of

Groups at risk and population burden of iron deficiency anaemia

Iron deficiency anaemia is most prevalent in pregnant and breastfeeding women and in children younger than 5 years, particularly those born prematurely or with a low birthweight. Other groups might nonetheless be at substantial risk, depending on the age-specific and sex-specific prevalence and intensity of infections that cause blood loss. Women of reproductive age, particularly adolescent girls, are at high risk of having insufficient iron stores at conception to maintain iron balance during

Risk factors for iron deficiency

From an early age, the diet of children in sub-Saharan Africa is mainly constituted of low-quality, grain-based complementary foods that are a poor source of absorbable iron. A meta-analysis of nationally representative surveys in sub-Saharan African countries found that only 31% (range 7–70%) of infants aged 0–5 months are predominantly breastfed,24 and that early introduction (at age 3–6 months) of non-fortified complementary plant-based foods is a risk factor for anaemia.25 Because of the

Determining the iron status of individuals and populations

In clinical practice in sub-Saharan Africa, the diagnosis of iron deficiency is usually based on signs and symptoms, sometimes supplemented with point-of-care assays to measure haemoglobin concentration or haematocrit, and with possible exclusion of other causes of anaemia for which point-of-care tests might be available (eg, dipstick test for plasmodium infections).

In the absence of inflammation, circulating ferritin concentrations indicate total body iron stores. Ferritin concentration is the

Potential benefits of iron interventions

Table 2 summarises key results of meta-analyses of randomised controlled trials to assess the effects of daily iron supplementation as a conservative indication of potential benefits from iron interventions in various risk groups. Most trials included in these meta-analyses were done outside of sub-Saharan Africa.

Antenatal iron supplementation was found to reduce the risk of severe post-partum anaemia by 96% (table 2). A previous meta-analysis37 reported a risk reduction in the mother receiving

Iron interventions and infections

Chronic or repeated infections due to Plasmodium spp, helminths, and other pathogens are common and cause a high prevalence of inflammation in sub-Saharan African populations. For example, in nationally or regionally representative community-based surveys in sub-Saharan Africa, the prevalence of inflammation (serum C-reactive protein concentration >5 mg/L or serum alpha-1-acid glycoprotein concentration >1 g/L) varied in the ranges of 48·5–67·5% (five surveys) for preschool-aged children and of

Interventions

WHO-recommended policies aimed at controlling iron deficiency or anaemia, or that can affect iron status, are listed in appendix 2 (pp 4–5); the applicability of each policy can be assessed per country and population group by cross-classifying with data in appendix 2 (p 6).

Discussion

Two iron interventions are safe and stand out for their potential contribution towards meeting Sustainable Development Goals and WHO global nutrition targets.

First, adherence to iron supplementation in pregnancy probably leads to substantial reductions in post-partum, haemorrhage-induced maternal mortality and increased birthweight. Studies are needed to determine why some countries have much higher coverage than others. The finding that adherence is associated with the number of antenatal

Search strategy and selection criteria

References for this Series paper were identified through searches of PubMed with the search terms “iron deficiency”, “anaemia”, in combination with “iron”, “supplementation”, “fortificat*”, “biofortifi*”, “Africa”, “helminth*”, “hookworm”, “schistosomiasis”, “malaria”, for publications between Jan 1, 2010, and Oct 31, 2020, in English exclusively. We focused on randomised controlled trials as identified in reviews and meta-analyses. Articles were also identified through searches of the authors'

Declaration of interests

We declare no competing interests.

References (80)

  • A Ghanchi et al.

    Guts, germs, and iron: a systematic review on iron supplementation, iron fortification, and diarrhea in children aged 4–59 months

    Curr Dev Nutr

    (2019)
  • S Sazawal et al.

    Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial

    Lancet

    (2006)
  • S-R Pasricha et al.

    Net benefit and cost-effectiveness of universal iron-containing multiple micronutrient powders for young children in 78 countries: a microsimulation study

    Lancet Glob Health

    (2020)
  • DM Ba et al.

    Adherence to iron supplementation in 22 sub-Saharan African countries and associated factors among pregnant women: a large population-based study

    Curr Dev Nutr

    (2019)
  • JD Haas et al.

    Iron-biofortified rice improves the iron stores of nonanemic Filipino women

    J Nutr

    (2005)
  • JL Finkelstein et al.

    A randomized trial of iron-biofortified pearl millet in school children in India

    J Nutr

    (2015)
  • JD Haas et al.

    Consuming iron biofortified beans increases iron status in Rwandan women after 128 days in a randomized controlled feeding trial

    J Nutr

    (2016)
  • CM Chaparro et al.

    Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomised controlled trial

    Lancet

    (2006)
  • H Ritchie et al.

    Urbanization. November, 2019. Our World In Data

  • The global prevalence of anaemia in 2011

    (2015)
  • H Wang et al.

    Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

    Lancet

    (2020)
  • E Loaiza et al.

    Adolescent pregnancy: a review of the evidence

    (2013)
  • Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity

    (2011)
  • CDC criteria for anemia in children and childbearing-aged women

    MMWR Morb Mortal Wkly Rep

    (1989)
  • MN Mwangi et al.

    Safety and benefits of antenatal oral iron supplementation in low-income countries: a review

    Br J Haematol

    (2017)
  • Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc

    (2001)
  • LA Sanga et al.

    Inter-pregnancy interval and associated adverse maternal outcomes among women who delivered at Kilimanjaro Christian Medical Centre in Tanzania, 2000–2015

    PLoS One

    (2020)
  • MN Mwangi et al.

    Effect of daily antenatal iron supplementation on Plasmodium infection in Kenyan women: a randomized clinical trial

    JAMA

    (2015)
  • JM Muriuki et al.

    Estimating the burden of iron deficiency among African children

    BMC Med

    (2020)
  • SD Harlow et al.

    Epidemiology of menstrual disorders in developing countries: a systematic review

    BJOG

    (2004)
  • C Borzutzky et al.

    Diagnosis and management of heavy menstrual bleeding and bleeding disorders in adolescents

    JAMA Pediatr

    (2020)
  • N Petry et al.

    The proportion of anemia associated with iron deficiency in low, medium, and high human development index countries: a systematic analysis of national surveys

    Nutrients

    (2016)
  • Global burden of disease study 2019 (GBD 2019) population estimates 1950–2019

  • Global all-cause deaths and DALYs for 2019 with trends since 1990

  • RJ Stoltzfus et al.

    Iron deficiency anaemia

  • SP Scott et al.

    The impact of anemia on child mortality: an updated review

    Nutrients

    (2014)
  • AI Issaka et al.

    Prevalence of key breastfeeding indicators in 29 sub-Saharan African countries: a meta-analysis of demographic and health surveys (2010–2015)

    BMJ Open

    (2017)
  • F Wang et al.

    Age of complementary foods introduction and risk of anemia in children aged 4–6 years: a prospective birth cohort in China

    Sci Rep

    (2017)
  • Vitamin and mineral requirements in human nutrition

  • AK Deol et al.

    Schistosomiasis—assessing progress toward the 2020 and 2025 Global Goals

    N Engl J Med

    (2019)
  • Cited by (0)

    View full text